A startup company developing treatments for inflammatory diseases based on a research partnership between The University of Queensland and Trinity College Dublin has been acquired in a landmark deal – one of the largest in Australian and Irish...
22 September 2020
Inflazome Ltd, a company founded on research from The University of Queensland (UQ) and Trinity College Dublin, has closed a Series A financing round of up to €15 million (A$22 million).
12 September 2016
A University of Queensland research team has been awarded a grant from The Michael J. Fox Foundation for Parkinson’s Research to target brain inflammation in people with Parkinson’s disease.
6 March 2015
